Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Clinical studies of ENB-0040 in hypophosphatasia patients reported

June 26, 2009

GPR119 agonist MBX-2982 shows potential in treating diabetes

June 26, 2009

Safety, pharmacokinetic results with ZYH-1 in healthy subjects reported

June 26, 2009

Shanghai Hengrui discovers novel CETP inhibitors for the treatment of lipoprotein disorders

June 25, 2009

GTx Inc. describes estrogen receptor-beta agonist for obesity treatment

June 25, 2009

Cordex Pharma and Clinical Trials International sign license agreement for ATPotent

June 25, 2009

Biovitrum transfers preclinical GPR-119 and SCD-1 diabetes projects to iNovacia

June 25, 2009

Improved lean body mass by MK-0773 not associated with hypertrophic prostatic activity

June 25, 2009

Diamyd vaccine proven safe and immunogenic in children and adolescents with type 1 diabetes

June 25, 2009

Interim data from phase II trials support the potential of SB-509 in diabetic peripheral neuropathy

June 25, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...